EPO and ischemia: In adult animal model studies, EPO treatment was observed to reduce cardiac ischemia/reperfusion injury, attributed in part to stimulation of NO production and as an acute response prior to increase in hematocrit [80,87], although EpoR was not detected in human heart and EPO signaling was not detected in rat neonatal cardiac myocytes [74].